NeuroVive Pharmaceutical AB ADR

(NRVVY)

By |

Profile

Abliva AB is a Swedish company which is active in pharmaceutical development. Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly. The portfolio includes projects at different stages and ranges from early discovery phase to clinical phase.

Contact Information

Website: www.abliva.com
Main Phone: +46 462756220
Address: Medicon Village
Address 2: Scheelevagen 2
City / Town: Lund
Country: SE
Postal Code: SE-22381

Issuer Information

Exchange: GREY
Employees: 9

Equities News

Profile

Abliva AB is a Swedish company which is active in pharmaceutical development. Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly. The portfolio includes projects at different stages and ranges from early discovery phase to clinical phase.

Contact Information

Website: www.abliva.com
Main Phone: +46 462756220
Address: Medicon Village
Address 2: Scheelevagen 2
City / Town: Lund
Country: SE
Postal Code: SE-22381

Issuer Information

Exchange: GREY
Employees: 9

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 3,147,368.00 EPS (TTM) -3.40 PE Ratio N/A Exchange Greys